Targovax announces successful NOK 200 million private placement
Reference is made to the announcement from Targovax AS ("Targovax" or the "Company") dated 11 June 2015 regarding the acquisition of Oncos Therapeutics Oy ("Oncos") and the contemplated private placement to raise NOK 125 - 150 million which, as announced on 15 June 2015, was upsized to NOK 200 million (the "Private Placement").After strong investor demand and feedback from reputable institutional investors, Targovax is pleased to announce that it has allocated 8,000,000 shares at a price of NOK 25 per share raising total gross proceeds of NOK 200 million in the Private Placement. The